Related Experiment Video
Updated: May 6, 2026

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro
Published on: June 16, 2022
TNFα contributes for attenuating both Y397FAK and Y416Src phosphorylations in osteoblasts
Adm Cavagis1, Er Takamori, Jm Granjeiro
1Federal University of São Carlos (UFSCar), Sorocaba, Brazil.
Objective:
Our poor understanding of how inflammatory mediators can affect osteoblast behavior led us to investigate the tumor necrosis factor (TNF)α-induced focal adhesion kinase (FAK) and Src phosphorylation.
Material And Methods:
MC3T3-E1 pre-osteoblast cells were harvested at specific time points after either TNFα treatment or RAW267 stimulated conditioned medium, and thereafter cell extracts were prepared for Immunoblotting assay. ELISA detected TNFα content at conditioned medium. Tumor necrosis factor-α-neutralizing antibodies also were used.
Results:
It was possible to show that TNFα provokes attenuation at Y-phosphorylation of both FAK (at Y397 ) and Src (at Y416 ) proteins (P < 0.05), suggesting a decrease in their activities. The very similar profile was observed when osteoblasts were incubated with conditioned medium from lipopolysaccharide (LPS)-stimulated macrophages, it being significantly different than control (FAK and Src, P < 0.05). Nevertheless, in order to validate these findings, we decided to pre-incubate osteoblasts with anti-TNFα neutralizing antibody (2 μg ml(-1) ) prior exposing to conditioned medium. Importantly, our results revealed that there was a diminution on those conditioned medium effects when the same biological parameters were evaluated (P < 0.05). Moreover, we also showed that TNFα impairs osteoblast adhesion, suggesting an interesting role on osteoblast performance.
Conclusions:
Altogether, these results suggest that LPS-stimulated macrophage mediators attenuate both FAK and Src activations in osteoblast, suggesting a novel role for TNFα on osteoblast performance.
Insights
Tumor necrosis factor-alpha (TNFα) reduces osteoblast function by decreasing focal adhesion kinase (FAK) and Src activity. This inflammatory mediator impacts osteoblast adhesion and performance, revealing a novel regulatory role.
Area of Science:
- Cell Biology
- Immunology
- Biochemistry
Background:
- Inflammatory mediators significantly impact bone cell function.
- Osteoblast behavior is poorly understood in the context of inflammation.
Purpose of the Study:
- Investigate the effect of tumor necrosis factor-alpha (TNFα) on focal adhesion kinase (FAK) and Src phosphorylation in osteoblasts.
- Elucidate the role of inflammatory mediators in regulating osteoblast activity.
Main Methods:
- MC3T3-E1 pre-osteoblast cells were treated with TNFα or macrophage-conditioned medium.
- Immunoblotting was used to assess FAK and Src phosphorylation.
- ELISA measured TNFα levels, and neutralizing antibodies were employed.
Main Results:
- TNFα treatment significantly attenuated FAK (Y397) and Src (Y416) phosphorylation, indicating reduced activity.
- Conditioned medium from LPS-stimulated macrophages mimicked this effect.
- Anti-TNFα antibodies diminished the effects of conditioned medium, confirming TNFα's role.
- TNFα was shown to impair osteoblast adhesion.
Conclusions:
- Mediators from LPS-stimulated macrophages, particularly TNFα, attenuate FAK and Src activation in osteoblasts.
- TNFα plays a novel role in regulating osteoblast performance and adhesion.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
TGF - β Signaling Pathway
Osteoclasts in Bone Remodeling
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
NF-kB-dependent Signaling Pathway
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...

